bevacizumab,trifluridine tipiracil
roche,otsuka,taiho pharma
[]
 is shining today #gi23 #crcsm
sunlight ph3 tas102+/-bev in refractory mcrc
n=492, ps 0-1 76% prior bev mos 10.8 v 7.5m 3.3m hr 0.61 sig
qol, safety tas102 not yet reimbursed in so our is 3.3m+ recourse 2.8m = 6.1m os new soc 
Cancer Doctor, Professor, Lifelong Learner #GI #Cancer 🇨🇦 @UBC @BCCancer @CCTG #Prez @CAMO #TEDxSpeaker #MedTwitter @OncoAlert Tweets are my own